NZ191709A - Naphtylmethyl-piperidines and pharmaceutical compostions intermediates - Google Patents

Naphtylmethyl-piperidines and pharmaceutical compostions intermediates

Info

Publication number
NZ191709A
NZ191709A NZ191709A NZ19170979A NZ191709A NZ 191709 A NZ191709 A NZ 191709A NZ 191709 A NZ191709 A NZ 191709A NZ 19170979 A NZ19170979 A NZ 19170979A NZ 191709 A NZ191709 A NZ 191709A
Authority
NZ
New Zealand
Prior art keywords
naphtylmethyl
piperidines
intermediates
pharmaceutical compostions
compostions
Prior art date
Application number
NZ191709A
Other languages
English (en)
Inventor
A Carr
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of NZ191709A publication Critical patent/NZ191709A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ191709A 1979-02-09 1979-10-01 Naphtylmethyl-piperidines and pharmaceutical compostions intermediates NZ191709A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/010,555 US4246268A (en) 1979-02-09 1979-02-09 Neuroleptic-4-(naphthylmethyl)piperidine derivatives

Publications (1)

Publication Number Publication Date
NZ191709A true NZ191709A (en) 1981-12-15

Family

ID=21746302

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ191709A NZ191709A (en) 1979-02-09 1979-10-01 Naphtylmethyl-piperidines and pharmaceutical compostions intermediates

Country Status (22)

Country Link
US (1) US4246268A (US07166745-20070123-C00016.png)
JP (1) JPS55105665A (US07166745-20070123-C00016.png)
AT (1) AT374458B (US07166745-20070123-C00016.png)
AU (1) AU526777B2 (US07166745-20070123-C00016.png)
BE (1) BE881624A (US07166745-20070123-C00016.png)
CA (1) CA1120036A (US07166745-20070123-C00016.png)
CH (1) CH643542A5 (US07166745-20070123-C00016.png)
DE (1) DE3002292A1 (US07166745-20070123-C00016.png)
DK (1) DK152669C (US07166745-20070123-C00016.png)
ES (1) ES486824A1 (US07166745-20070123-C00016.png)
FR (1) FR2448531A1 (US07166745-20070123-C00016.png)
GB (1) GB2041918B (US07166745-20070123-C00016.png)
HK (1) HK96887A (US07166745-20070123-C00016.png)
IE (1) IE48485B1 (US07166745-20070123-C00016.png)
IL (1) IL58687A (US07166745-20070123-C00016.png)
IT (1) IT1120639B (US07166745-20070123-C00016.png)
NL (1) NL190193C (US07166745-20070123-C00016.png)
NO (1) NO153725C (US07166745-20070123-C00016.png)
NZ (1) NZ191709A (US07166745-20070123-C00016.png)
PH (1) PH16648A (US07166745-20070123-C00016.png)
SE (1) SE448725B (US07166745-20070123-C00016.png)
ZA (1) ZA795131B (US07166745-20070123-C00016.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443462A (en) * 1979-08-06 1984-04-17 Merrell Dow Pharmaceuticals Inc. Antipsychotic 4-(naphthalenyloxy)piperidine derivatives
FR2484415A1 (fr) * 1980-06-13 1981-12-18 Pharmindustrie Nouveaux derives de l'indene, procedes pour leur preparation, et leur utilisation comme medicaments
FR2560873B1 (fr) * 1984-03-09 1986-09-26 Rhone Poulenc Sante Medicaments a base de derives de la piperidine, nouveaux derives de la piperidine et leurs procedes de preparation
WO1987002359A1 (en) * 1985-10-14 1987-04-23 Maggioni-Winthrop S.P.A. Dihydrobenzothiophene and thiochromane aminoalcohols
US4757079A (en) * 1986-06-24 1988-07-12 Dynamac Corporaton Anti-hypertensive piperidine compounds
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
JP2573195B2 (ja) * 1986-09-30 1997-01-22 エーザイ株式会社 環状アミン誘導体
US5523307A (en) * 1987-11-27 1996-06-04 Eisai Co., Ltd. Cyclic amine and pharmacological composition
US5196439A (en) * 1987-11-27 1993-03-23 Eisai Co., Ltd. Piperidine compounds useful to treat cerebrovascular diseases
US4921863A (en) * 1988-02-17 1990-05-01 Eisai Co., Ltd. Cyclic amine derivatives
WO1990006303A1 (en) * 1988-12-02 1990-06-14 Pfizer Inc. Arylpiperidine derivatives
US5077035A (en) * 1990-05-14 1991-12-31 The University Of Michigan Radioiodinated benzovesamicol analogs for cholinergic nerve mapping
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
FR2664592B1 (fr) * 1990-07-10 1994-09-02 Adir Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
US6303627B1 (en) * 1998-06-19 2001-10-16 Eli Lilly And Company Inhibitors of serotonin reuptake

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR86403E (fr) * 1959-05-01 1966-02-04 May & Baker Ltd Nouveaux dérivés de la phényl-4 pipéridine et leur préparation
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
US3453283A (en) * 1965-12-30 1969-07-01 Abbott Lab Novel 6-substituted-1-(piperidyl-alkyl)-1,2,3,4-tetrahydronaphthalenes
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
ZA717147B (en) * 1970-11-27 1972-07-26 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)-4'-fluorobutyrophenone derivatives
BE791088A (fr) * 1971-11-09 1973-03-01 Richardson Merrell Inc Nouveaux derives d'aryl (piperidyl-4) cetone, utiles notamment comme analgesiques et anticoagulants, et leur procede de preparation
BE794333A (fr) * 1972-01-20 1973-07-19 Wyeth John & Brother Ltd Composes heterocycliques azotes therapeutiques
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3888867A (en) * 1972-05-03 1975-06-10 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)4'-fluorobutyrophenone derivatives
US4101662A (en) * 1973-05-03 1978-07-18 A. H. Robins Company, Incorporated Method for inhibiting emesis and compositions therefor
SE7409245L (US07166745-20070123-C00016.png) * 1973-07-19 1975-01-20 Robins Co Inc A H
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
DE2718405A1 (de) * 1977-04-26 1978-11-02 Boehringer Sohn Ingelheim Neue n- eckige klammer auf 1-(3-benzoylpropyl)-4-piperidyl eckige klammer zu -sulfonsaeureamide und verfahren zu deren herstellung

Also Published As

Publication number Publication date
NO153725C (no) 1986-05-14
SE8000920L (sv) 1980-08-10
NL7907686A (nl) 1980-08-12
NO800338L (no) 1980-08-11
AU526777B2 (en) 1983-01-27
PH16648A (en) 1983-12-06
JPS6341901B2 (US07166745-20070123-C00016.png) 1988-08-19
SE448725B (sv) 1987-03-16
CA1120036A (en) 1982-03-16
ZA795131B (en) 1980-10-29
FR2448531B1 (US07166745-20070123-C00016.png) 1983-09-09
AT374458B (de) 1984-04-25
AU5161079A (en) 1980-08-14
DE3002292C2 (US07166745-20070123-C00016.png) 1990-01-25
HK96887A (en) 1987-12-24
IE791851L (en) 1980-08-09
DK152669C (da) 1988-08-22
IE48485B1 (en) 1985-02-06
NO153725B (no) 1986-02-03
JPS55105665A (en) 1980-08-13
IT7950921A0 (it) 1979-11-27
ATA54880A (de) 1983-09-15
IT1120639B (it) 1986-03-26
GB2041918A (en) 1980-09-17
NL190193B (nl) 1993-07-01
GB2041918B (en) 1983-03-23
IL58687A (en) 1983-07-31
DK152669B (da) 1988-04-11
DE3002292A1 (de) 1980-08-21
FR2448531A1 (fr) 1980-09-05
CH643542A5 (de) 1984-06-15
IL58687A0 (en) 1980-02-29
NL190193C (nl) 1993-12-01
DK55980A (da) 1980-08-10
ES486824A1 (es) 1980-10-01
BE881624A (fr) 1980-05-30
US4246268A (en) 1981-01-20

Similar Documents

Publication Publication Date Title
NZ188151A (en) Triphenylalkene derivatives and pharmaceutical compostions
ZA803567B (en) Pharmaceutical preparations
NZ189438A (en) Perhaloalkylvinylcyclopropanecarboxylates intermediates and pharmaceutical compositions
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
IL59150A0 (en) N-benzyl-imidazoles,their preparation and pharmaceutical compostions containing them
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
NZ188170A (en) Propenylamines and pharmaceutical compositions
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
NZ191709A (en) Naphtylmethyl-piperidines and pharmaceutical compostions intermediates
NZ194584A (en) -lactam antibiotics and pharmaceutical compositions
JPS55100313A (en) Drug composition and its manufacture
DE3071122D1 (en) 6-alpha-fluoro-9-alpha-chloro-prednisolone-17,21 diesters, pharmaceutical compositions containing them and intermediates
NZ184394A (en) N-acyl-l-alanyl -aminoacyl-amides intermediates and pharmaceutical compositions
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
ZA803535B (en) Novel quinazoline derivatives and pharmaceutical preparations
PH16369A (en) Novel quinazoline derivatives and pharmaceutical preparation
JPS559074A (en) Compound and drug composition
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
NZ193557A (en) 4-phenylchroman derivatives intermediates and pharmaceutical compositions
DE3064789D1 (en) New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
JPS5470255A (en) Nnbenzylanthracycline and pharmaceutical composition
PH12590A (en) 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
GB2048250B (en) 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them